DYDA: Left Ventricular DYsfunction in DiAbetes

Sponsor
Heart Care Foundation (Other)
Overall Status
Completed
CT.gov ID
NCT01971125
Collaborator
(none)
970
14
52
69.3
1.3

Study Details

Study Description

Brief Summary

The purpose of this study is to evaluate the prevalence, during the enrolment, of Left Ventricular Dysfunction diastolic and/or systolic in patients with diabetes mellitus type 2 without known or documented heart disease history and recognize its predictive clinical, biohumoral and with non-invasive techniques parameters.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    970 participants
    Observational Model:
    Case-Only
    Time Perspective:
    Prospective
    Official Title:
    Left Ventricular DYsfunction in DiAbetes
    Study Start Date :
    Jul 1, 2006
    Actual Primary Completion Date :
    Mar 1, 2009
    Actual Study Completion Date :
    Nov 1, 2010

    Arms and Interventions

    Arm Intervention/Treatment
    No treatment

    Patients with: diabetes mellitus type 2 absence of heart disease previously reported age >45 years Informed Consent Patients without: presence of heart disease previously reported diabetes type 1 serious systemic disease, with an expected lifetime lower than 2 years no willingness to participate to the screening inadequate compliance to study procedure participation to other study

    Outcome Measures

    Primary Outcome Measures

    1. Prevalence of Left Ventricular Dysfunction in patients with type II diabetes [left ventricula dysfunction at enrollment]

      To evaluate the prevalence of left ventricular dysfunction (LVD), diastolic or systolic in patients with type II diabetes mellitus in the absence of clinical signs/symptoms of cardiac abnormalities To identify the predictors of LVD

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    45 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • diabetes mellitus type 2

    • absence of heart disease previously reported

    • age >45 years

    • Informed Consent

    Exclusion Criteria:
    • presence of heart disease previously reported

    • diabetes type 1

    • serious systemic disease, with an expected lifetime lower than 2 years

    • no willingness to participate to the screening

    • inadequate compliance to study procedure

    • participation to other study

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Casa di Cura Pineta del Carso Duino - Aurisina Friuli - Venezia Giulia Italy 34011
    2 A.O.- Univ. Ospedali Riuniti Trieste Friuli - Venezia Giulia Italy 34100
    3 Azienda Servizi Sanitari N°1 Triestina Trieste Friuli - Venezia Giulia Italy 34100
    4 Presidio Ospedaliero Sanremo Liguria Italy 18038
    5 Ospedali Riuniti Bergamo Lombardia Italy 24100
    6 Spedali Civili Brescia Lombardia Italy 25100
    7 Ospedale San Raffaele Milano Lombardia Italy 20010
    8 Ospedale San Paolo Milano Lombardia Italy 20100
    9 Istituto Clinico Humanitas Rozzano Lombardia Italy 20089
    10 IRCCS Policlinico Multimedica Sesto San Giovanni Lombardia Italy 20099
    11 Ospedale Maggiore Chieri Piemonte Italy 10023
    12 A.O. Santa Croce e Carle Cuneo Piemonte Italy 12100
    13 Ospedale Mauriziano Torino Piemonte Italy 10125
    14 Ospedale Civile Mirano Veneto Italy 30035

    Sponsors and Collaborators

    • Heart Care Foundation

    Investigators

    • Study Chair: Marco Comaschi, M.D.,
    • Study Chair: Andrea di Lenarda, M.D.,

    Study Documents (Full-Text)

    None provided.

    More Information

    Additional Information:

    Publications

    Responsible Party:
    Heart Care Foundation
    ClinicalTrials.gov Identifier:
    NCT01971125
    Other Study ID Numbers:
    • G 107
    First Posted:
    Oct 29, 2013
    Last Update Posted:
    Feb 3, 2021
    Last Verified:
    Oct 1, 2013

    Study Results

    No Results Posted as of Feb 3, 2021